Q2
BLFS — Q2 2026 Financial Report Analysis
BioLife's Q2 2026 revenue rose 21% to $28.5M on demand for its CryoStor freezing media; a $42.4M one-off tax benefit inflated net income to $45.1M in its last quarter as a standalone company before Repligen's takeover.